Blog Read the latest perspectives from our team of subject matter experts and others Provider Data Has Become InfrastructureEvery health plan is investing in digital transformation, AI, and better member experiences. Yet all of those initiatives ultimately depend on one thing: confidence in the underlying provider data. At… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Artificial IntelligenceProvider DataHealthcare Predictions 2026: Market Shifts That Will Define the IndustryFor 2026, we predict four significant developments in healthcare: provider data regulations will require new compliance standards, health plans will make consumer experience a top strategic priority to win new… Continue reading → Read the articleno Drug DevelopmentUnlocking Smarter Clinical Trial Feasibility with Connected DataWhen it comes to clinical trial feasibility, the stakes are high. Choosing the wrong sites or drafting a protocol without full visibility into patient populations can lead to costly… Continue reading → Read the articleno KOL EngagementFrom Fragmented to Connected: Unlocking the Power of 360° HCP EngagementAt Fierce Pharma Week 2025, Stacey Rivkin took the stage to address one of pharma’s most persistent challenges: despite having more data than ever before, medical and commercial teams still… Continue reading → Read the articleno KOL EngagementHow H1 Integrates with Your CRM of ChoiceAt H1, we know that every life sciences organization has unique needs when it comes to customer relationship management (CRM). Some companies rely on long-established platforms, while others are adopting… Continue reading → Read the articleno Drug DevelopmentBridging the Feasibility Gap: A Smarter Path to Clinical Trial EnrollmentDespite decades of progress in data access and analytics, the clinical research industry continues to struggle with one seemingly simple challenge: enrolling patients on time. The statistics are stark: nearly… Continue reading → Read the articleno Drug DevelopmentWhy More Data Hasn’t Improved Clinical Trial EnrollmentIn clinical trial feasibility, we face a counterintuitive reality: despite unprecedented access to healthcare professional data, identifying the right investigators and predicting enrollment success has become increasingly challenging. This… Continue reading → Read the articleno‹1234567›»
